[VIPoma: surgical treatment].

Abstract

This paper reports a case of pancreatic VIPoma with widespread hepatic metastasis which was treated for approximately 2 years with a synthetic somatostatin analog (SMS 201/995). The treatment of choice in cases in which the tumour was fully removable is surgical resection. This occurred rarely since approximately 80% of VIPomas are malignant and are operated late when local infiltration is already widespread; in addition, 50% of cases are already metastasised at diagnosis. In this case, due to the infiltration of the superior mesenteric artery by the primary tumour it was necessary to carry out a left pancreasectomy which included two-thirds of the neoplastic mass. This was justified by slow tumour growth and also facilitated control of diarrhea and ensured a greater efficacy of possible postoperative chemotherapy. The use of synthetic somatostatin analog (SMS 201/995) enabled diarrhea to be satisfactorily controlled and is therefore specifically indicated for this type of tumour. NSE serum assay (neuron specific enolase) allowed the evolution of disease to be monitored during follow-up.

• Authors: F Procacciante, P Picozzi, A Fantini, M Pacifici, A Di Nardo, G Ribotta, G Delle Fave, M Catani, S Ruggeri, F Romeo
• Journal: Minerva chirurgica (Minerva Chir) Vol. 47 Issue 3-4 Pg. 135-42 (Feb 1992) ISSN: 0026-4733 [Print] Italy
• Vernacular Title: VIPoma: trattamento chirurgico.
• PMID: 1314346 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Phosphopyruvate Hydratase

Topics

• Female
• Humans
• Liver Neoplasms (secondary)
• Middle Aged
• Pancreatic Neoplasms (enzymology, surgery)
• Phosphopyruvate Hydratase (blood)
• Vipoma (enzymology, secondary, surgery)